ARQT insider trading — Arcutis Biotherapeutics, Inc.
Over the last 90 days, insiders at Arcutis Biotherapeutics, Inc. (ARQT) made 0 open-market purchases worth $0 and 5 open-market sales worth $1.42M, making them net sellers by $1.42M. The largest sale was by Curran Terrie (Director), who sold 38,200 shares for $956K on Aug 27, 2026.
Updated Oct 16, 2026.
Recent ARQT insider transactions
Every Form 4 filed by Arcutis Biotherapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Matsuda Masaru | See Remarks | S · Sale · 10b5-1 | Direct | 3,674 | $25.00 | $92K | Form 4 |
| Sep 15, 2026 | Welgus Howard G. | Director | M · Option exercise · 10b5-1 | Direct | 4,096 | $7.93 | $32K | Form 4 |
| Sep 15, 2026 | Welgus Howard G. | Director | S · Sale · 10b5-1 | Direct | 4,730 | $24.18 | $114K | Form 4 |
| Sep 8, 2026 | Matsuda Masaru | See Remarks | S · Sale · 10b5-1 | Direct | 9,989 | $25.03 | $250K | Form 4 |
| Aug 27, 2026 | Curran Terrie | Director | M · Option exercise | Direct | 38,200 | $8.30 | $317K | Form 4 |
| Aug 27, 2026 | Curran Terrie | Director | S · Sale | Direct | 38,200 | $25.03 | $956K | Form 4 |
| Aug 20, 2026 | Curran Terrie | Director | M · Option exercise | Direct | 1,072 | $7.51 | $8K | Form 4 |
| Aug 20, 2026 | Curran Terrie | Director | S · Sale | Direct | 1,072 | $26.04 | $28K | Form 4 |
| Aug 19, 2026 | Burnett Patrick | See Remarks | S · Sale | Direct | 1,697 | $27.00 | $46K | Form 4 |
| Aug 17, 2026 | Welgus Howard G. | Director | M · Option exercise · 10b5-1 | Direct | 4,096 | $7.93 | $32K | Form 4 |
| Aug 17, 2026 | Welgus Howard G. | Director | S · Sale · 10b5-1 | Direct | 4,730 | $26.18 | $124K | Form 4 |
| Aug 12, 2026 | Burnett Patrick | See Remarks | M · Option exercise | Direct | 6,700 | $3.64 | $24K | Form 4 |
| Aug 12, 2026 | Burnett Patrick | See Remarks | S · Sale | Direct | 6,700 | $26.08 | $175K | Form 4 |
| Aug 11, 2026 | Burnett Patrick | See Remarks | M · Option exercise | Direct | 8,300 | $3.64 | $30K | Form 4 |
| Aug 11, 2026 | Burnett Patrick | See Remarks | S · Sale | Direct | 8,300 | $26.52 | $220K | Form 4 |
| Aug 3, 2026 | Burnett Patrick | See Remarks | S · Sale · 10b5-1 | Direct | 955 | $26.12 | $25K | Form 4 |
| Aug 3, 2026 | Matsuda Masaru | See Remarks | S · Sale · 10b5-1 | Direct | 1,230 | $26.12 | $32K | Form 4 |
| Aug 3, 2026 | Watanabe Todd | See Remarks | S · Sale · 10b5-1 | Direct | 4,375 | $26.12 | $114K | Form 4 |
ARQT insider trading FAQ
Are insiders buying ARQT stock?
Not on the open market. In the last 90 days, Arcutis Biotherapeutics, Inc. insiders made no open-market purchases, and 5 open-market sales totaling $1.42M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ARQT?
Recent sellers: Burnett Patrick, Curran Terrie.
Where does ARQT insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.